{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:19:41Z","timestamp":1771514381647,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ajg.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:58:06Z","timestamp":1762383486000},"page":"415-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of antiviral treatment in Chronic Hepatitis \u2212B (CHB) population"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1857-5086","authenticated-orcid":false,"given":"Tanu","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-5875","authenticated-orcid":false,"given":"Suchit","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajg.2025.09.008_b0005","unstructured":"www.who.int\/news\/item\/29-03-2024-who-publishes-updated-guidelines-on-hepatitis-b."},{"issue":"1","key":"10.1016\/j.ajg.2025.09.008_b0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21037\/atm-21-6272","article-title":"Prevalence and clinical characteristics of hepatitis B surface antigen-negative\/hepatitis B core antibody-positive patients with detectable serum hepatitis B virus DNA","volume":"10","author":"Cai","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ajg.2025.09.008_b0015","first-page":"13","article-title":"Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative","volume":"5","author":"Zeng","year":"2023","journal-title":"HBeAg negative Front Immunol"},{"key":"10.1016\/j.ajg.2025.09.008_b0020","series-title":"Antiviral Research","first-page":"47","article-title":"Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities","author":"Gish","year":"2015"},{"issue":"12","key":"10.1016\/j.ajg.2025.09.008_b0025","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.53350\/pjmhs2115123789","article-title":"Sero-prevalence and Associated Complications of Hepatitis B Virus Infected patients of Khyber Pakhtunkhwa","volume":"15","author":"Hassan","year":"2021","journal-title":"Pak J Medical Health Sci"},{"issue":"2","key":"10.1016\/j.ajg.2025.09.008_b0030","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice guidelines on the management of hepatitis B virus infection","volume":"67","author":"Lampertico","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.ajg.2025.09.008_b0035","first-page":"281","article-title":"Coexistence of HBsAg\/Anti-HBs and HBeAg\/Anti-HBe in Sudanese patients with Chronic Hepatitis B Virus Infection: a Cross-Sectional Study","volume":"13","author":"Hashim","year":"2023","journal-title":"Int J Biomed"},{"issue":"3","key":"10.1016\/j.ajg.2025.09.008_b0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ueg2.12376","article-title":"Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center","volume":"11","author":"Jachs","year":"2023","journal-title":"United European Gastroenterol J"},{"issue":"4","key":"10.1016\/j.ajg.2025.09.008_b0045","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2018.05.009","article-title":"Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B","volume":"69","author":"Wong","year":"2018","journal-title":"J Hepatol"},{"issue":"1094","key":"10.1016\/j.ajg.2025.09.008_b0050","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/postgradmedj-2016-134069","article-title":"Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection","volume":"92","author":"Diktas","year":"2016","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ajg.2025.09.008_b0055","series-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","first-page":"1","author":"Sarin","year":"2016"},{"issue":"1","key":"10.1016\/j.ajg.2025.09.008_b0060","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4269\/ajtmh.19-0129","article-title":"Albumin\u2013bilirubin score differentiates liver fibrosis stage and hepatocellular carcinoma incidence in chronic hepatitis B virus infection: a retrospective cohort study","volume":"101","author":"Fujita","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"10.1016\/j.ajg.2025.09.008_b0065","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1080\/21645515.2020.1732166","article-title":"Hepatitis B vaccine development and implementation","volume":"16","author":"Zhao","year":"2020","journal-title":"Hum Vaccin Immunother [Internet]"},{"key":"10.1016\/j.ajg.2025.09.008_b0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.19170","article-title":"Regional differences in mortality rates and characteristics of decedents with Hepatitis B listed as a cause of death, United States, 2000-2019","author":"Ly","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.ajg.2025.09.008_b0075","doi-asserted-by":"crossref","DOI":"10.1093\/pcmedi\/pbac030","article-title":"Expanding antiviral therapy indications for HBeAg-negative chronic hepatitis B patients with normal ALT and positive HBV DNA","volume":"5","author":"Zhou","year":"2022","journal-title":"Precis Clin Med"},{"key":"10.1016\/j.ajg.2025.09.008_b0080","article-title":"Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation","author":"Zhang","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"10.1016\/j.ajg.2025.09.008_b0085","first-page":"39","article-title":"Evaluation of serum HBV viral load, transaminases and histological features in chronic HBeAg-negative hepatitis B patients","volume":"10","author":"Esmaeelzadeh","year":"2017","journal-title":"Gastroenterol Hepatol bed bench"},{"key":"10.1016\/j.ajg.2025.09.008_b0090","article-title":"Rate and determinants of antiviral treatment initiation for patients with HBeAg-negative chronic hepatitis B","volume":"1","author":"Mutimer","year":"2023","journal-title":"J Viral Hepat"},{"issue":"8","key":"10.1016\/j.ajg.2025.09.008_b0095","first-page":"121","article-title":"Serological profile of chronic hepatitis B carriers \u2013 a tertiary care experience. asian","volume":"14","author":"Ramamurthy","year":"2023","journal-title":"J Med Sci"},{"issue":"2","key":"10.1016\/j.ajg.2025.09.008_b0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/apt.15311","article-title":"High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation","volume":"50","author":"Choi","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajg.2025.09.008_b0105","series-title":"The Lancet Gastroenterology and Hepatology","first-page":"406","article-title":"Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad","author":"Ghany","year":"2020"},{"issue":"502","key":"10.1016\/j.ajg.2025.09.008_b0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cca.2019.12.020","article-title":"Albumin-bilirubin score is associated with response to pegylated interferon and nucleos(t)ide analogues in chronic hepatitis B patients","volume":"1","author":"Xun","year":"2020","journal-title":"Clin Chim Acta"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197925001248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197925001248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:31:48Z","timestamp":1771511508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197925001248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1687197925001248"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2025.09.008","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of antiviral treatment in Chronic Hepatitis \u2212B (CHB) population","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}